Quantification of Human T-lymphotropic virus type I (HTLV-I) provirus load in a rural West African population: no enhancement of human immunodeficiency virus type 2 pathogenesis, but HTLV-I provirus load relates to mortality

J Infect Dis. 2003 Dec 1;188(11):1648-51. doi: 10.1086/379780. Epub 2003 Nov 14.

Abstract

Human T-lymphotropic virus type I (HTLV-I) provirus load was examined in a cohort of a population in Guinea-Bissau among whom human immunodeficiency virus (HIV) type 2 is endemic. Geometric mean of HIV-2 RNA load among HTLV-I-coinfected subjects was significantly lower than that in subjects infected with HIV-2 alone (212 vs. 724 copies/mL; P=.02). Adjusted for age, sex, and HIV status, the risk of death increased with HTLV-I provirus load; mortality hazard ratio was 1.59 for each log10 increase in HTLV-I provirus copies (P=.038). There is no enhancing effect of HTLV-I coinfection on HIV-2 disease, but high HTLV-I provirus loads may contribute to mortality.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acquired Immunodeficiency Syndrome / immunology
  • Acquired Immunodeficiency Syndrome / mortality
  • Acquired Immunodeficiency Syndrome / virology*
  • Adult
  • CD4 Lymphocyte Count
  • Cohort Studies
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Guinea-Bissau
  • HIV-2 / pathogenicity*
  • Human T-lymphotropic virus 1 / isolation & purification*
  • Humans
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Proviruses / isolation & purification*
  • RNA, Viral / analysis
  • Viral Load*

Substances

  • RNA, Viral